{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T11:23:04Z","timestamp":1782386584236,"version":"3.54.5"},"reference-count":34,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacological and Toxicological Methods"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1016\/j.vascn.2013.02.006","type":"journal-article","created":{"date-parts":[[2013,2,21]],"date-time":"2013-02-21T19:33:38Z","timestamp":1361475218000},"page":"148-161","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Influence of surgically implantable telemetry solutions on in-life and post-mortem toxicology endpoints"],"prefix":"10.1016","volume":"67","author":[{"given":"Theodore J.","family":"Baird","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Bailie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Patrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Moddrelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Yoder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David V.","family":"Gauvin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill A.","family":"Dalton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vascn.2013.02.006_bb0005","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.smim.2007.11.004","article-title":"Foreign body reaction to biomaterials","volume":"20","author":"Anderson","year":"2008","journal-title":"Seminars in Immunology"},{"key":"10.1016\/j.vascn.2013.02.006_bb0010","series-title":"S7A: Safety Pharmacology Studies for Human Pharmaceuticals (ICH S7A)","article-title":"U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER), Guidance for Industry","author":"Anon","year":"2001"},{"key":"10.1016\/j.vascn.2013.02.006_bb0015","series-title":"S7B: The Non-clinical Evaluation of the Potential for Delayed Ventricular Repolarization (QT Interval Prolongation) by Human Pharmaceuticals (ICH S7B)","article-title":"U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER), Guidance for Industry","author":"Anon","year":"2005"},{"key":"10.1016\/j.vascn.2013.02.006_bb0020","series-title":"S6: Preclinical Safety Evaluation of Biotechnology Derived Pharmaceuticals. ICH S6","article-title":"U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER), Guidance for Industry","author":"Anon","year":"1997"},{"key":"10.1016\/j.vascn.2013.02.006_bb0025","series-title":"S9: Nonclinical Evaluation for Anticancer Pharmaceuticals (ICH S9)","article-title":"U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER), Guidance for Industry","author":"Anon","year":"2010"},{"key":"10.1016\/j.vascn.2013.02.006_bb0030","series-title":"M3(R2): Non-Clinical Safety Studies for the Conduct of Human Clinical Trials and Marketing Authorization for Pharmaceuticals. ICH M3(R2)","article-title":"U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER), Guidance for Industry","author":"Anon","year":"2010"},{"key":"10.1016\/j.vascn.2013.02.006_bb0040","series-title":"Handbook of Toxicology","article-title":"Acute, Subchronic, and Chronic Toxicology","author":"Auletta","year":"2002"},{"key":"10.1016\/j.vascn.2013.02.006_bb0045","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.vascn.2011.05.007","article-title":"Evaluation of a novel ECG lead placement method in telemetered freely moving cynomolgus monkeys: Assessment of an intravascular biopotential lead","volume":"64","author":"Authier","year":"2011","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"key":"10.1016\/j.vascn.2013.02.006_bb0050","first-page":"e42","article-title":"Influence of the local laboratory environment and selection of telemetry application on quantitative ECG sensitivity","volume":"64","author":"Baird","year":"2011","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"key":"10.1016\/j.vascn.2013.02.006_bb0055","unstructured":"Baird, T. J., O'Donohue, K., Posthumus, T., Eliel, M. W., Gauvin, D. V., & Dalton, J. A. (in press). Comparison of Telemetry Derived Epicardial and Intravascular Electrocardiogram Characteristics in Beagle Dogs. Journal of Pharmacological and Toxicological Methods."},{"key":"10.1016\/j.vascn.2013.02.006_bb0060","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.vascn.2004.02.004","article-title":"Introduction to nonclinical safety pharmacology and the safety pharmacology society","volume":"49","author":"Bass","year":"2004","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"key":"10.1016\/j.vascn.2013.02.006_bb0065","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.vascn.2011.04.001","article-title":"J. ECG arrhythmias in non-implanted vs. telemetry-implanted dogs: Need for screening before and sufficient recovery time after implantation","volume":"64","author":"Cools","year":"2011","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"key":"10.1016\/j.vascn.2013.02.006_bb0070","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1517\/14740338.2010.510131","article-title":"Cardiovascular system assessment best practices: A Safety Pharmacology Society meeting","volume":"9","author":"Cavero","year":"2010","journal-title":"Expert Opinion on Drug Safety"},{"key":"10.1016\/j.vascn.2013.02.006_bb0075","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.vascn.2008.12.001","article-title":"Prevalence and types of spontaneous cardiac arrhythmias recorded in three experimentally- and drug-na\u00efve laboratory species (canine, primate, swine) used in toxicology and safety assessment studies","volume":"59","author":"Gauvin","year":"2009","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"key":"10.1016\/j.vascn.2013.02.006_bb0080","series-title":"Handbook of Pre-clinical Continuous Intravenous Infusion","article-title":"The ambulatory model in dog multidose infusion toxicity studies","author":"Gleason","year":"2000"},{"key":"10.1016\/j.vascn.2013.02.006_bb0085","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.vascn.2009.05.006","article-title":"Comparison of electrocardiographic analysis for risk of QT interval prolongation using safety pharmacology and toxicological studies","volume":"60","author":"Guth","year":"2009","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"key":"10.1016\/j.vascn.2013.02.006_bb0090","first-page":"49","article-title":"Evaluation of quantitative and morphological characteristics of the electrocardiogram as recorded simultaneously by non-invasive and standard implantable telemetry in beagle dogs and cynomolgus monkeys","volume":"28","author":"Harter","year":"2009","journal-title":"International Journal of Toxicology"},{"key":"10.1016\/j.vascn.2013.02.006_bb0095","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.vascn.2010.05.017","article-title":"Left thoracotomy surgical approach for chronic instrumentation in dogs and monkeys providing high quality electrocardiogram signals","volume":"62","author":"Henriques","year":"2010","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"key":"10.1016\/j.vascn.2013.02.006_bb0100","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1016\/j.vascn.2011.03.155","article-title":"Incidence of Arrhythmia in Cynomolgus Monkeys Instrumented for Telemetry with Epicardial (EPI) ECG Lead Orientation","volume":"64","author":"Holdsworth","year":"2011","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"issue":"2","key":"10.1016\/j.vascn.2013.02.006_bb0105","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.vascn.2006.05.007","article-title":"Novel probabilistic method for precisely correcting the QT interval for heart rate in telemetered dogs and cynomolgus monkeys","volume":"55","author":"Holzgrefe","year":"2007","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"issue":"2","key":"10.1016\/j.vascn.2013.02.006_bb0110","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.2460\/javma.1974.164.12.1192","article-title":"Calcinosis circumscripta in a dog","volume":"164","author":"Legendre","year":"1974","journal-title":"Journal of the American Veterinary Medical Association"},{"issue":"3","key":"10.1016\/j.vascn.2013.02.006_bb0115","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.vascn.2011.08.006","article-title":"Best practice in the conduct of key nonclinical cardiovascular safety assessments in drug development: Current recommendations from the Safety Pharmacology Society","volume":"65","author":"Leishman","year":"2012","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"key":"10.1016\/j.vascn.2013.02.006_bb0120","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.vascn.2008.07.001","article-title":"Benchmarking safety pharmacology regulatory packages and best practice","volume":"58","author":"Lindgren","year":"2008","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"key":"10.1016\/j.vascn.2013.02.006_bb0125","doi-asserted-by":"crossref","first-page":"375","DOI":"10.2131\/jts.22.5_375","article-title":"Current status of conducting function tests in repeated dose toxicity studies in Japan","volume":"22","author":"Matsuzawa","year":"1997","journal-title":"Journal of Toxicological Sciences"},{"key":"10.1016\/j.vascn.2013.02.006_bb0130","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.vascn.2010.05.018","article-title":"Evaluation of blood pressure measurement using a miniature blood pressure transmitter with jacketed external telemetry in cynomolgus monkeys","volume":"62","author":"McMahon","year":"2010","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"key":"10.1016\/j.vascn.2013.02.006_bb0135","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.vascn.2012.08.107","article-title":"A step-wise approach to quantitative arrhythmia assessment: A multi-species and multi-drug validation","volume":"66","author":"O'Donohue","year":"2011","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"key":"10.1016\/j.vascn.2013.02.006_bb0140","series-title":"Handbook of Toxicology","article-title":"Animal Histopathology","author":"Peckham","year":"2002"},{"key":"10.1016\/j.vascn.2013.02.006_bb0145","series-title":"Handbook of Pre-clinical Continuous Intravenous Infusion","article-title":"The non-ambulatory model in dog multidose infusion toxicity studies","author":"Pickersgill","year":"2000"},{"issue":"2","key":"10.1016\/j.vascn.2013.02.006_bb0150","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1080\/01926230390183706","article-title":"The incidence of thymic B lymphoid follicles in healthy beagle dogs","volume":"31","author":"Ploermen","year":"2003","journal-title":"Toxicologic Pathology"},{"key":"10.1016\/j.vascn.2013.02.006_bb0155","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.vascn.2009.06.001","article-title":"Non-invasive telemetric electrocardiogram assessment in conscious beagle dogs","volume":"60","author":"Prior","year":"2009","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"key":"10.1016\/j.vascn.2013.02.006_bb0160","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1177\/1091581811398963","article-title":"Cardiovascular function in nonclinical drug safety assessment: Current issues and opportunities","volume":"30","author":"Sarazan","year":"2011","journal-title":"International Journal of Toxicology"},{"issue":"2","key":"10.1016\/j.vascn.2013.02.006_bb0165","doi-asserted-by":"crossref","first-page":"147","DOI":"10.4142\/jvs.2004.5.2.147","article-title":"Idiopathic canine polyarteritis in control beagle dogs from toxicity studies","volume":"5","author":"Son","year":"2004","journal-title":"Journal of Veterinary Science"},{"key":"10.1016\/j.vascn.2013.02.006_bb0170","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.vascn.2008.04.001","article-title":"Scientific review and recommendations on preclinical cardiovascular safety evaluation of biologics","volume":"58","author":"Vargas","year":"2008","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"issue":"5","key":"10.1016\/j.vascn.2013.02.006_bb0175","doi-asserted-by":"crossref","first-page":"575","DOI":"10.2460\/javma.239.5.575","article-title":"What is your diagnosis? Calcinosis circumscripta","volume":"239","author":"Zwicker","year":"2011","journal-title":"Journal of the American Veterinary Medical Association"}],"container-title":["Journal of Pharmacological and Toxicological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056871913002098?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056871913002098?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T23:56:52Z","timestamp":1761004612000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1056871913002098"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["S1056871913002098"],"URL":"https:\/\/doi.org\/10.1016\/j.vascn.2013.02.006","relation":{},"ISSN":["1056-8719"],"issn-type":[{"value":"1056-8719","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Influence of surgically implantable telemetry solutions on in-life and post-mortem toxicology endpoints","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmacological and Toxicological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vascn.2013.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}